Skip to main content

Want a detailed portfolio tracker?

Cabaletta Bio (CABA) P/E (2019 - 2026)

Cabaletta Bio (CABA) P/E from Dec 31, 2019 to Jun 3, 2026. The TTM Cabaletta Bio (CABA) P/E is -2.60. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cabaletta Bio (CABA)

YearP/EChange
2026-2.60+83.65%
2025-1.41-1.44%
2024-1.44-92.38%
2023-18.85+141.09%
2022-7.82+140.89%
2021-3.25-75.85%
2020-13.44-85.52%
2019-92.80N/A

Comparison Cabaletta Bio (CABA) P/E with competitors

Cabaletta Bio (CABA) P/E is -2.60.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.10-103.93%
ENLVEnlivex Therapeutics Ltd0.15-105.78%
FGENFibroGen Inc0.24-109.24%
TRAWTraws Pharma Inc0.47-118.19%
FBIOFortress Biotech Inc0.71-127.17%
CHRSCoherus Biosciences Inc0.98-137.64%
ORMPOramed Pharmaceuticals Inc1.47-156.70%
AGENAgenus Inc2.05-178.83%
VIVSVivoSim Labs Inc2.54-197.58%
INVAInnoviva Inc3.19-222.70%
CRMDCorMedix Inc3.65-240.29%
ABEOAbeona Therapeutics Inc4.20-261.82%
VXRTVaxart Inc4.26-264.00%
CVACCureVac N.V.4.45-271.08%
SRPTSarepta Therapeutics Inc4.62-277.95%
GLPGGalapagos NV4.86-286.98%
RIGLRigel Pharmaceuticals4.92-289.31%
ZVRAZevra Therapeutics Inc4.97-291.41%
ABUSArbutus Biopharma Corp5.69-319.11%
CGENCompugen Ltd7.38-384.15%
AUPHAurinia Pharmaceuticals Inc9.25-456.02%
ACADAcadia Pharmaceuticals Inc9.59-468.97%
OMEROmeros Corporation9.88-480.34%
PLXProtalix BioTherapeutics Inc9.91-481.33%
SPROSpero Therapeutics Inc10.73-513.10%
ADMAAdma Biologics Inc11.33-536.03%
SVASinovac Biotech Ltd11.44-540.09%
TBPHTheravance Biopharma Inc11.78-553.20%
HRMYHarmony Biosciences Holdings Inc12.18-568.74%
TGTXTG Therapeutics Inc13.18-607.18%
INCYIncyte Corp13.38-614.98%
SABSSAB Biotherapeutics Inc14.06-640.98%
XOMAXOMA Corp14.95-675.13%
REGNRegeneron Pharmaceuticals Inc14.98-676.48%
PBYIPuma Biotechnology Inc15.05-679.18%
EXELExelixis Inc15.79-707.83%
NAGENiagen Bioscience Inc16.35-729.38%
CPRXCatalyst Pharmaceuticals Inc17.34-767.47%
MDXGMimedx Group Inc17.38-768.65%
ARGXArgen X SE23.07-987.86%
HALOHalozyme Therapeutics Inc23.20-992.82%
XOMAOXOMA Corp25.34-1075.34%
VRTXVertex Pharmaceuticals Inc25.66-1087.31%
XOMAPXOMA Corp25.67-1087.86%
CTMXCytomX Therapeutics Inc25.70-1088.93%
ASNDAscendis Pharma A/S26.35-1114.18%
RPRXRoyalty Pharma plc - Class A27.50-1158.10%
SLNOSoleno Therapeutics Inc29.02-1216.59%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1261.66%
BMRNBiomarin Pharmaceutical Inc37.51-1543.38%
APLSApellis Pharmaceuticals Inc39.02-1601.64%
KRYSKrystal Biotech Inc39.70-1627.67%
GMABGenmab40.20-1647.15%
ONCBeiGene Ltd67.03-2679.38%
TECHBio-Techne Corp68.59-2739.73%
VCELVericel Corp80.63-3202.84%
PHARPharming Group N.V.87.74-3476.49%
ALNYAlnylam Pharmaceuticals Inc124.93-4907.80%
TLXTelix Pharmaceuticals Ltd139.89-5483.39%
CORTCorcept Therapeutics Inc158.39-6195.27%